These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 26327487)

  • 21. Translation and validation of the Urdu version of the European organization for research and treatment of cancer core quality of life questionnaire (EORTC QLQ-C30) and brain module (QLQ-BN20) in primary brain tumor patients.
    Zahid N; Martins RS; Zahid W; Khalid W; Azam I; Bhamani SS; Asad N; Ahmad K; Jabbar AA; Shamim MS; Khan RJ; Javed G; Bari E; Enam SA
    J Patient Rep Outcomes; 2021 Sep; 5(1):79. PubMed ID: 34487251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Summary scores captured changes in subjects' QoL as measured by the multiple scales of the EORTC QLQ-C30.
    Phillips R; Gandhi M; Cheung YB; Findlay MP; Win KM; Hai HH; Yang JM; Lobo RR; Soo KC; Chow PK
    J Clin Epidemiol; 2015 Aug; 68(8):895-902. PubMed ID: 25843232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of the Taiwan Chinese version of the EORTC QLQ-CR29 to assess quality of life in colorectal cancer patients.
    Shen MH; Chen LP; Ho TF; Shih YY; Huang CS; Chie WC; Huang CC
    BMC Cancer; 2018 Apr; 18(1):353. PubMed ID: 29606101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life.
    Bergman B; Aaronson NK; Ahmedzai S; Kaasa S; Sullivan M
    Eur J Cancer; 1994; 30A(5):635-42. PubMed ID: 8080679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brazilian Validation of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group (QLG) Computerised Adaptive Tests (CAT) Core.
    Marta GN; de Souza TYT; Silva ARNSE; Pereira APA; Ferreira Neto DR; Asso RN; Degrande FAM; Nader-Marta G; da Silva MF; Gadia R; Hanna SA; Holzner B; Saad ED; Petersen MA
    Curr Oncol; 2021 Aug; 28(5):3373-3383. PubMed ID: 34590597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-c30): validation of English version in Singapore.
    Luo N; Fones CS; Lim SE; Xie F; Thumboo J; Li SC
    Qual Life Res; 2005 May; 14(4):1181-6. PubMed ID: 16041912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EORTC QLQ-C30 general population normative data for the United States.
    Rogge AA; Liegl G; Snyder C; Rose M; Nolte S;
    Eur J Cancer; 2024 May; 202():114030. PubMed ID: 38552543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross-cultural verification of the EORTC QLQ-C15-PAL questionnaire in mainland China.
    Zhang L; Wang N; Zhang J; Liu J; Luo Z; Sun W; Woo SM; Chen C; Zhang K; Miller AR; Guo H; Zhang X; Wang C
    Palliat Med; 2016 Apr; 30(4):401-8. PubMed ID: 26121985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychometric Properties of the Fatigue Questionnaire EORTC QLQ-FA12 in a Sample of Female Cancer Patients.
    Kecke S; Ernst J; Einenkel J; Singer S; Hinz A
    J Pain Symptom Manage; 2017 Dec; 54(6):922-928. PubMed ID: 28807705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive factors of overall well-being using the EORTC QLQ-C15-PAL extracted from the EORTC QLQ-C30.
    Lam K; Zeng L; Zhang L; Tseng LM; Hou MF; Fairchild A; Vassiliou V; Jesus-Garcia R; Alm El-Din MA; Kumar A; Forges F; Chie WC; Sahgal A; Poon M; Chow E
    J Palliat Med; 2013 Apr; 16(4):402-8. PubMed ID: 23458649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Derivation of utility values from European Organization for Research and Treatment of Cancer Quality of Life-Core 30 questionnaire values in lung cancer.
    Jang RW; Isogai PK; Mittmann N; Bradbury PA; Shepherd FA; Feld R; Leighl NB
    J Thorac Oncol; 2010 Dec; 5(12):1953-7. PubMed ID: 21155140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. International validation of a health-related quality-of-life questionnaire for Hodgkin lymphoma: the EORTC QLQ-HL27.
    Oerlemans S; Efficace F; Shamieh O; Cardoso Borges F; de Jong C; Dong D; Lehmann J; Malak S; Petranovic D; Scholz CW; Caocci G; Molica S; Griskevicius L; Nagele E; Bredart A; Carvalho E; Xochelli A; Agelink van Rentergem J; Alrjoob W; Mueller A; Freitas AC; Cocks K; Creutzberg C; Kyriakou C; van de Poll-Franse L
    Blood Adv; 2023 Nov; 7(22):7045-7055. PubMed ID: 37738090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validating and improving the reliability of the EORTC qlq-c30 using a multidimensional Rasch model.
    Shih CL; Chen CH; Sheu CF; Lang HC; Hsieh CL
    Value Health; 2013; 16(5):848-54. PubMed ID: 23947980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular health-related quality of life in cancer: a prospective study comparing the ESC HeartQoL and EORTC QLQ-C30 questionnaire.
    Anker MS; Potthoff SK; Lena A; Porthun J; Hadzibegovic S; Evertz R; Denecke C; Fröhlich AK; Sonntag F; Regitz-Zagrosek V; Rosen SD; Lyon AR; Lüscher TF; Spertus JA; Anker SD; Karakas M; Bullinger L; Keller U; Landmesser U; Butler J; von Haehling S
    Eur J Heart Fail; 2023 Sep; 25(9):1635-1647. PubMed ID: 37369985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Minimally important differences for interpreting the EORTC QLQ-C30 in patients with advanced colorectal cancer treated with chemotherapy.
    Musoro JZ; Sodergren SC; Coens C; Pochesci A; Terada M; King MT; Sprangers MAG; Groenvold M; Cocks K; Velikova G; Flechtner HH; Bottomley A;
    Colorectal Dis; 2020 Dec; 22(12):2278-2287. PubMed ID: 32767619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Further evaluation of the EORTC QLQ-C30 psychometric properties in a large Brazilian cancer patient cohort as a function of their educational status.
    Paiva CE; Carneseca EC; Barroso EM; de Camargos MG; Alfano AC; Rugno FC; Paiva BS
    Support Care Cancer; 2014 Aug; 22(8):2151-60. PubMed ID: 24652051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identifying health-related quality of life cut-off scores that indicate the need for supportive care in young adults with cancer.
    Lidington E; Giesinger JM; Janssen SHM; Tang S; Beardsworth S; Darlington AS; Starling N; Szucs Z; Gonzalez M; Sharma A; Sirohi B; van der Graaf WTA; Husson O
    Qual Life Res; 2022 Sep; 31(9):2717-2727. PubMed ID: 35476170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the EORTC QLQ-C30 questionnaire: a comparison with SF-36 Health Survey in a cohort of Italian long-survival cancer patients.
    Apolone G; Filiberti A; Cifani S; Ruggiata R; Mosconi P
    Ann Oncol; 1998 May; 9(5):549-57. PubMed ID: 9653497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association of liver function and quality of life of patients with liver cancer.
    Li L; Mo F; Hui EP; Chan SL; Koh J; Tang NLS; Yu SCH; Yeo W
    BMC Gastroenterol; 2019 May; 19(1):66. PubMed ID: 31046687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
    Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
    Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.